These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35753963)

  • 21. [Real-world adherence to oral anticoagulants in atrial fibrillation].
    Simonyi G; Paksy A; Várnai R; Medvegy M
    Orv Hetil; 2020 May; 161(20):839-845. PubMed ID: 32364687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in utilization of warfarin and direct oral anticoagulants in older adult patients with atrial fibrillation.
    Alalwan AA; Voils SA; Hartzema AG
    Am J Health Syst Pharm; 2017 Aug; 74(16):1237-1244. PubMed ID: 28652320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Switching of oral anticoagulants in atrial fibrillation: a cohort study using Australian general practice data.
    Kefale AT; Peterson GM; Bezabhe WM; Bereznicki LR
    Expert Rev Clin Pharmacol; 2022 Mar; 15(3):351-357. PubMed ID: 35184624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation.
    Forslund T; Wettermark B; Hjemdahl P
    Eur J Clin Pharmacol; 2016 Mar; 72(3):329-38. PubMed ID: 26613954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Adherence to Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Comparative Cross-Sectional Study.
    Gulpen AJW; Braeken DCW; Schalla S; Ten Cate H; Crijns HJ; Ten Cate-Hoek AJ
    Acta Haematol; 2022; 145(5):476-483. PubMed ID: 35306490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of direct oral anticoagulants in patients with atrial fibrillation in Scotland: Applying a coherent framework to drug utilisation studies.
    Mueller T; Alvarez-Madrazo S; Robertson C; Bennie M
    Pharmacoepidemiol Drug Saf; 2017 Nov; 26(11):1378-1386. PubMed ID: 28752670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases.
    Maura G; Billionnet C; Alla F; Gagne JJ; Pariente A
    Pharmacotherapy; 2018 Jan; 38(1):6-18. PubMed ID: 29028119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
    Marzec LN; Wang J; Shah ND; Chan PS; Ting HH; Gosch KL; Hsu JC; Maddox TM
    J Am Coll Cardiol; 2017 May; 69(20):2475-2484. PubMed ID: 28521884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adherence to oral anticoagulants in patients with non-valvular atrial fibrillation: the role of patients' characteristics and out-of-pocket payments.
    Al-Obaidi S; Hijazeen R; Arabyat RM; Alabbadi I
    Expert Rev Pharmacoecon Outcomes Res; 2024 Sep; 24(7):845-852. PubMed ID: 38967473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticoagulation adherence and its associated factors in patients with atrial fibrillation: a cross-sectional study.
    Chen PT; Wang TJ; Hsieh MH; Liu JC; Liu CY; Wang KY; Laio WC
    BMJ Open; 2019 Sep; 9(9):e029974. PubMed ID: 31481562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry.
    Sciria CT; Maddox TM; Marzec L; Rodwin B; Virani SS; Annapureddy A; Freeman JV; O'Hare A; Liu Y; Song Y; Doros G; Zheng Y; Lee JJ; Daggubati R; Vadlamani L; Cannon C; Desai NR
    Clin Cardiol; 2020 Jul; 43(7):743-751. PubMed ID: 32378265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study.
    Banerjee A; Benedetto V; Gichuru P; Burnell J; Antoniou S; Schilling RJ; Strain WD; Ryan R; Watkins C; Marshall T; Sutton CJ
    Heart; 2020 Jan; 106(2):119-126. PubMed ID: 31601729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Ozaki AF; Choi AS; Le QT; Ko DT; Han JK; Park SS; Jackevicius CA
    Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e005969. PubMed ID: 32148102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic.
    Lee SI; Sayers M; Lip GY; Lane DA
    Int J Clin Pract; 2015 Nov; 69(11):1341-8. PubMed ID: 26234557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-World Clinical Characteristics and Treatment Patterns of Individuals Aged 80 and Older with Nonvalvular Atrial Fibrillation: Results from the ReAl-life Multicenter Survey Evaluating Stroke Study.
    Biteker M; Başaran Ö; Doğan V; Altun İ; Özpamuk Karadeniz F; Tekkesin Aİ; Çakıllı Y; Türkkan C; Hamidi M; Demir V; Gürsoy MO; Tek Öztürk M; Aksan G; Seyis S; Ballı M; Alıcı MH; Bozyel S
    J Am Geriatr Soc; 2017 Aug; 65(8):1684-1690. PubMed ID: 28394435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in Uptake and Adherence to Oral Anticoagulation for Patients With Incident Atrial Fibrillation at High Stroke Risk Across Health Care Settings.
    Yogasundaram H; Dover DC; Hawkins NM; McAlister FA; Goodman SG; Ezekowitz J; Kaul P; Sandhu RK
    J Am Heart Assoc; 2022 Aug; 11(15):e024868. PubMed ID: 35876419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysis.
    Blomström Lundqvist C; Själander S; Garcia Rodriguez LA; Åkerborg Ö; Jin G; Caleyachetty A; Huelsebeck M; Bowrin K; Schaefer B; Mahdessian H; Hofmeister L; Levin LÅ
    J Med Econ; 2022; 25(1):1085-1091. PubMed ID: 35997241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adequate Adherence to Direct Oral Anticoagulant is Associated with Reduced Ischemic Stroke Severity in Patients with Atrial Fibrillation.
    Yamashiro K; Kurita N; Tanaka R; Ueno Y; Miyamoto N; Hira K; Nakajima S; Urabe T; Hattori N
    J Stroke Cerebrovasc Dis; 2019 Jun; 28(6):1773-1780. PubMed ID: 30318259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A mixed methodology, non-interventional study to evaluate the use of direct oral anticoagulants in UK clinical practice for patients with a first stroke associated with non-valvular atrial fibrillation: study protocol.
    Bhat Y; Dixit A; Mistri A; Patel B; Quoraishi SH; Uprichard J
    BMC Neurol; 2019 Nov; 19(1):306. PubMed ID: 31783738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of Trends in Guideline-Based Oral Anticoagulant Prescription for Patients With Ischemic Stroke and Atrial Fibrillation in China.
    Gu HQ; Yang X; Wang CJ; Zhao XQ; Wang YL; Liu LP; Meng X; Jiang Y; Li H; Liu C; Xiong YY; Fonarow GC; Wang D; Xian Y; Li ZX; Wang YJ
    JAMA Netw Open; 2021 Jul; 4(7):e2118816. PubMed ID: 34323982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.